Identification of disease-promoting HLA class I and protective class II modifiers in Japanese patients with familial Mediterranean fever

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Yasunami, Michio ^a   Nakamura, Hitomi ^a   Agematsu, Kazunaga ^b   Nakamura, Akinori ^c   Yazaki, Masahide ^c   Kishida, Dai ^c   Yachie, Akihiro ^d   Toma, Tomoko ^d   Masumoto, Junya ^e   Ida, Hiroaki ^f   Koga, Tomohiro ^g   Kawakami, Atsushi ^g   Eguchi, Katsumi ^h   Furukawa, Hiroshi ⁱ   Nakamura, Tadashi ^j   Nakamura, Minoru ^k   Migita, Kiyoshi ^k  

^a NAGASAKI UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h Sasebo Shiritsu Sogo Hospital   (Japan)

ⁱ SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^j Kumamoto Shinto General Hospital   (Japan)

^k NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; HLA B ANTIGEN; HLA DRB1 ANTIGEN; CYTOSKELETON PROTEIN; MEFV PROTEIN, HUMAN; PYRIN;

ADULT; ALLELE; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DRB1 GENE; FAMILIAL MEDITERRANEAN FEVER; GENE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HLA B GENE; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MEFV GENE; PHENOTYPE; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; FEMALE; GENETICS; JAPAN; MALE; MIDDLE AGED; MUTATION; YOUNG ADULT;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENES, MHC CLASS I; GENOTYPE; HLA-B ANTIGENS; HLA-DRB1 CHAINS; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PYRIN; YOUNG ADULT;

EID: 84929377754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125938     Document Type: Article

References (32)

1. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351: 659-664. PMID: 9500348
2. Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterran.ean fever and next-of-kin. Nat Rev Rheumatol 2014; 10: 135-147. doi: 10.1038/nrrheum.2013.174 PMID: 24247370
3. Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 2009; 27: 621-668. doi: 10.1146/annurev.immunol.25.022106.141627 PMID: 19302049
4. Koné-Paut I, Hentgen V, Guillaume-Czitrom S, Compeyrot-Lacassagne S, Tran TA, Touitou I. The clinical spectrum of 94 patients carrying a single mutated MEFV allele. Rheumatology (Oxford) 2009; 48: 840-842. doi: 10.1093/rheumatology/kep121 PMID: 19465590
5. Touitou I.Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature. J Med Genet 2013; 50: 349-359. doi: 10.1136/jmedgenet-2013-101577 PMID: 23536687
6. Migita K, Uehara R, Nakamura Y, Yasunami M, Tsuchiya-Suzuki A, Yazaki M, et al. Familial Mediterranean fever in Japan. Medicine (Baltimore) 2012; 91: 337-343. doi: 10.1097/MD.0b013e318277cf75 PMID: 23111802
7. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67. PMID: 9433870
8. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-1213. PMID: 2446635
9. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 1982; 100: 1455-1458. PMID: 6956266
10. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-1885. PMID: 9336425
11. Tokunaga K, Ishikawa Y, Ogawa A, Wang H, Mitsunaga S, Moriyama S, et al. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 1997; 46: 199-205. PMID: 9211745
12. Bravo MJ, Colmenero Jde D, Alonso A, Caballero A. HLA-B∗39 allele confers susceptibility to osteoarticular complications in human brucellosis. J Rheumatol 2003; 30: 1051-1053. PMID: 12734905
13. Yamaguchi A, Tsuchiya N, Mitsui H, Shiota M, Ogawa A, Tokunaga K, et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum 1995; 38: 1672-1677. PMID: 7488289
14. Sobao Y, Tsuchiya N, Takiguchi M, Tokunaga K. Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies. Arthritis Rheum 1999; 42: 175-181. PMID: 9920028
15. Yagüe J, Alvarez I, Rognan D, Ramos M, Vázquez J, de Castro JA. An N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivo. J Exp Med 2000; 191: 2083-2092. PMID: 10859333
16. Robinson WP, van der Linden SM, Khan MA, Rentsch HU, Cats A, Russell A, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum 1989; 32: 1135-1141. PMID: 2789045
17. Brown MA, Pile KD, Kennedy LG, Calin A, Darke C, Bell J, et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996; 55: 268-270. PMID: 8733445
18. Wei JC, Tsai WC, Lin HS, Tsai CY, Chou CT.HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford) 2004; 43: 839-842. PMID: 15113995
19. Furukawa H, Kawasaki A, Oka S, Ito I, Shimada K, Sugii S, et al. Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1∗13:02 and∗14:03. PLoS One 2014; 9: e87792. doi: 10.1371/journal.pone.0087792 PMID: 24498373
20. Oka S, Furukawa H, Kawasaki A, Shimada K, Sugii S, Hashimoto A, et al. Protective effect of the HLA-DRB1∗13:02 allele in Japanese rheumatoid arthritis patients. PLoS One 2014; 9: e99453. doi: 10.1371/journal.pone.0099453 PMID: 24911054
21. Ueda S, Oryoji D, Yamamoto K, Noh JY, Okamura K, Noda M, et al. Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J Clin Endocrinol Metab 2014; 99: E379-383. doi: 10.1210/jc.2013-2841 PMID: 24285682
22. Terao C, Ohmura K, Ikari K, Kochi Y, Maruya E, Katayama M, et al. ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese. PLoS One 2012; 7: e40067 doi: 10.1371/journal.pone.0040067 PMID: 22792215
23. Ben-Chetrit E, Cohen R, Chajek-Shaul T. Familial mediterranean fever and Behçet's disease - are they associated? J Rheumatol 2002; 29: 530-534. PMID: 11908568
24. Akar S, Soysal O, Balci A, Solmaz D, Gerdan V, Onen F, et al. High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection. Arthritis Res Ther 2013; 15: R21. doi: 10.1186/ar4154 PMID: 23356447
25. Touitou I, Magne X, Molinari N, Navarro A, Quellec AL, Picco P, et al. MEFV mutations in Behçet's disease. Hum Mutat 2000; 16: 271-272. PMID: 10980540
26. Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003; 21(Suppl 30): S35-37. PMID: 14727457
27. Cosan F, Ustek D, Oku B, Duymaz-Tozkir J, Cakiris A, Abaci N, et al. Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum 2010; 62: 3232-3236. doi: 10.1002/art.27683 PMID: 20669279
28. Kirino Y, Zhou Q, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, et al. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease. Proc Natl Acad Sci U S A 2013; 110: 8134-8139. doi: 10.1073/pnas.1306352110 PMID: 23633568
29. Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 2009; 146: 467-478. doi: 10.1111/j.1365-2141.2009.07733.x PMID: 19466978
30. Ben-Chetrit E, Ozdogan H. Non-response to colchicine in FMF - definition, causes and suggested solutions. Clin Exp Rheumatol 2008; 26(Suppl 50): S49-51. PMID: 19026114
31. Tufan A, Babaoglu MO, Akdogan A, Yasar U, Calguneri M, Kalyoncu U, et al. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J Rheumatol 2007; 34: 1540-1544. PMID: 17610314
32. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005; 365: 1500-1505. PMID: 15850636